Philips buys American cardiac care company BioTelemetry in $2.8 billion deal

Philips said it would pay $72 per outstanding BioTelemetry share in cash, in an offer supported by the U.S. company’s board at a 16.5% premium to the stock’s closing price on Thursday.
Read More

Leave a Comment

Your email address will not be published. Required fields are marked *